Adherence and persistence to oral antidiabetic therapy in a managed care population

被引：0
|
作者：
Margolis, Jay
Costa, Laurie
Fee, Kelly
Plauschinat, Craig
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A559 / A559
页数：1
相关论文
共 50 条
  • [1] Oral antidiabetic medication adherence and glycemic control in managed care
    Rozenfeld, Yelena
    Hunt, Jacquelyn S.
    Plauschinat, Craig
    Wong, Ken S.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (02): : 71 - 75
  • [2] Persistence and adherence to statin therapy in a managed care setting
    Quach, C
    Nichol, MB
    Chen, L
    Patel, BV
    Berenbeim, D
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 330 - 331
  • [3] Statin therapy persistence in a managed care population
    Wang, SM
    Yang, W
    Nichol, MB
    Dow, T
    Johnson, KA
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A133 - A134
  • [4] MEDICATION ADHERENCE, PERSISTENCE, AND HEALTH CARE COSTS FOR PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATION
    Zhao, Z.
    Peng, X.
    Bae, J. P.
    Dungey, J.
    Faries, D. E.
    Sponseller, C. A.
    Wetmore, S.
    Yu, C. Y.
    LeNarz, L. A.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A43 - A43
  • [5] Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy
    Melikian, C
    White, TJ
    Vanderplas, A
    Dezii, CM
    Chang, E
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (03) : 460 - 467
  • [6] Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population
    Broder, Michael S.
    Chang, Eunice Y.
    Ory, Caron
    Kamath, Tripthi
    Sapra, Sandhya
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (02) : 148 - 157
  • [7] Refill persistence with oral antidiabetic therapy in Hungary
    Doro, Peter
    Benko, Ria
    Kosik, Edit
    Matuz, Maria
    Toth, Katalin
    Soos, Gyongyver
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S219 - S219
  • [8] MEDICATION NON-ADHERENCE AND NON-PERSISTENCE IN A MANAGED CARE DIABETES MELLITUS POPULATION
    Nichol, M. B.
    Wu, J.
    Knight, T. K.
    Liberman, J. N.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A103 - A103
  • [9] Persistence and compliance with omalizumab in a managed care population
    Gutierrez, B.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S160 - S160
  • [10] Comparision of adherence to antihypertensives in a managed care population
    Naik, RK
    Borrego, ME
    Gupchup, GV
    D'Angio, R
    Sabrsula, S
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 231 - 231
12345